Special Issue "ncRNA and Cancer Immunotherapy"
A special issue of Non-Coding RNA (ISSN 2311-553X).
Deadline for manuscript submissions: 31 March 2024 | Viewed by 74
Interests: ncRNAs; exosomes and extracellular vesicles; tumor heterogeneity; stem cells; oncolytic virus; cancer immunotherapy
Special Issues, Collections and Topics in MDPI journals
The convergence of immunotherapy and non-coding RNA (ncRNA) research opens up exciting possibilities for the development of personalized and targeted cancer treatments. By analyzing the ncRNA profiles of cancer patients, researchers can identify specific ncRNAs that can help stratify patients, predict treatment responses, and develop novel combination therapies. While cancer immunotherapy and ncRNA research hold tremendous promise, uncovering the complexity of ncRNA abundance, localization, and sub-stoichiometry in the complex dynamics of the immune response is crucial for their successful translation into clinical practice.
This Special Issue aims to assemble a collection of manuscripts containing original data and technical reviews on the functions of ncRNAs in the application of cancer immunotherapy worldwide, emphasizing their context-specific expression, scaffold interactions with other cellular components, and source of neoantigens. This Special Issue will also contribute to an extensive assessment of ncRNA’s role in maintaining immune homeostasis that tumors can co-opt to evade immune surveillance.
Dr. Agnieszka M. Bronisz
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Non-Coding RNA is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- non-coding RNA
- long non-coding RNAs
- circular RNA
- tumor immunity
- cancer immunotherapy
- ncRNA spatial structures
- ncRNA sub-stoichiometric activity
- ncRNAs as protein chaperones